SWEENY NICOLE (Chief Commercial Officer) reported 1 transaction at KALVISTA PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 6/11/2026ACC: 0001827505-26-000007
Officer· Chief Commercial Officer
Since Feb 2026
-361.79K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
5
Total transactions
361.79K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−59.29K
Price / share
—
Trade value
—
% of position
New position
6/11/2026
59.29K→0.00
Total
Net shares
−59.29K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/11/2026 | D · Disposition | −59.29K | — | — | New position | 59.29K | 0.00 |
| Total | −59.29K | $0.00 | ||||||
Derivative Transactions4
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
100K shares
Shares
−100K
Strike price
9.51
Held after
0.00
Exercisable
—
6/11/2026
Restricted Stock Unit
Direct
Converts to
Common Stock
40K shares
Shares
−40K
Strike price
Held after
0.00
Exercisable
—
6/11/2026
Restricted Stock Unit
Direct
Converts to
Common Stock
68.75K shares
Shares
−68.75K
Strike price
Held after
0.00
Exercisable
—
6/11/2026
Restricted Stock Unit
Direct
Converts to
Common Stock
93.75K shares
Shares
−93.75K
Strike price
Held after
0.00
Exercisable
—
6/11/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock100K shares | 6/11/2026 | D · Disposition | −100K | 9.51 | — | 0.00 |
| Restricted Stock Unit Direct | Common Stock40K shares | 6/11/2026 | D · Disposition | −40K | — | 0.00 | |
| Restricted Stock Unit Direct | Common Stock68.75K shares | 6/11/2026 | D · Disposition | −68.75K | — | 0.00 | |
| Restricted Stock Unit Direct | Common Stock93.75K shares | 6/11/2026 | D · Disposition | −93.75K | — | 0.00 |